High-throughput sequencing in vaccine research
Authors:
Open Access
- 31 May 2021
- journal article
- review article
- Published by Walter de Gruyter GmbH in Journal of Veterinary Research
- Vol. 65 (2) , 131-137
Abstract
The world of vaccines has changed tremendously since the time of Louis Pasteur. In the present day, it is regarded as vaccinology, a discipline which includes not only the knowledge of vaccine production, strategies for its delivery and influence on the clinical course of disease and the response of the host immune system but also regulatory, ethical, economic and ecological aspects of their use. A hundred years after Pasteur created the first vaccine, there was another scientific breakthrough of great importance in this field, i. e. Sanger sequencing. Progress in genome sequencing and other molecular techniques over the intervening 40 years has been enormous. High-throughput sequencing (HTS) platforms and bioinformatics tools are becoming widely available, falling in cost, and results are achieved very quickly. They enable the construction of modern vaccines, as well as the assessment of their safety, effectiveness and impact on the host organism and the environment. These techniques can also provide a tool for quality control of vaccines. Unprecedented possibilities are opened up by the HTS technique, but limiting factors on its implementation have to be contended with such as lack of reference materials and problems with method optimisation or validation. In the face of the current COVID-19 pandemic, a significant role is allotted to this sequencing technique while an effective vaccine against the disease caused by SARS-CoV-2 is sough.Keywords
This publication has 39 references indexed in Scilit:
- A novel navigated laser system brings new efficacy to the treatment of retinovascular disordersOman Journal of Ophthalmology, 2013
- Reverse Vaccinology: Developing Vaccines in the Era of GenomicsImmunity, 2010
- Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2Virus Research, 2010
- Next-generation sequencing: a transformative tool for vaccinologyExpert Review of Vaccines, 2009
- CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV‐Infected Adults Achieves Long‐Term Seroprotection for Up to 5 YearsClinical Infectious Diseases, 2008
- DDBJ with new system and faceNucleic Acids Research, 2007
- EMBL Nucleotide Sequence Database in 2006Nucleic Acids Research, 2006
- Accurate Multiplex Polony Sequencing of an Evolved Bacterial GenomeScience, 2005
- Genome sequencing in microfabricated high-density picolitre reactorsNature, 2005
- Reverse vaccinologyCurrent Opinion in Microbiology, 2000